About clinical supply services

IMP serves as your single point of contact for all clinical trial supply management needs
Welcome to IMP Clinical Supply Services, where excellence meets innovation in the realm of clinical trial supply management. From startups and small biotechs to global pharmaceutical companies, clinical trial sponsors turn to IMP for high-quality, tailored solutions that enable the efficient supply management of clinical trials. Our team of experts is passionate about quality in clinical trials and focused on providing top-notch services across clinical trial stages and phases.
Join us on a journey where precision meets compassion, compliance meets innovation, and your clinical trials find a trusted partner in IMP Clinical Supply Services.

Our services

At IMP Clinical Supply Services, we are more than just a service provider; we are your dedicated and professional partner, committed to excellence in every phase of your clinical trial. Our comprehensive clinical supply management solutions are tailored to meet the unique and evolving needs of your trial, ensuring that your journey is marked by efficiency, compliance, and success.

Our proactive approach and strategic planning serve as the foundation for a seamless clinical trial experience. We understand that each trial is distinct, and our team of experts is ready to navigate the intricacies with precision. From the initial stages of importation to the final steps of distribution, returns, and export/destruction, our commitment is unwavering. Our range of services includes:

Our team

A dedicated and professional team who provides comprehensive clinical supply management for your clinical trial.
Amir Malka
Chairman & Co-Founder

Amir is a seasoned leader with over two decades of experience in life sciences and clinical trials. As the Chairman of IMP Clinical Supply Services Ltd., a company he established in 2009, he drives innovation in clinical trial logistics and supply chain management. Amir holds an LL.B. and is a member of the Israeli Bar Association. His extensive experience and knowledge of clinical trials have been the driving force behind IMP vision since company inception. Amir is a member of several life science and clinical trial associations and is an active advocate in helping to break down barriers to further advance the life sciences and healthcare industries in Israel.

Limor Teomim
CEO

Limor has over 25 years of experience in the pharmaceutical and cannabis industries. At the establishment of IMP, Limor joined the team and has been an integral part of the company structure. She has taken a lead part in building the company culture, quality management, and systems. As CEO, Limor is leading the strategic and operational growth of the company to become a significant service provider for clinical studies sponsors. Limor brings her experience in both manufacturing and development of commercial and Investigational Medicinal Products, quality management systems, cGMP, GDP and local regulations to develop IMP into a top-quality leader in the field. Certified by both the American and Israeli quality societies as a Certified Manager of Quality (CMQ), she has served as a Quality Director of IMP and as VP Quality of Bioforum group. Prior to that, Limor held positions as Quality Manager for LycoRed Bio and Nesher Solutions and as a member of the Quality Assurance team at RAFA. Limor holds an M.Sc. Pharm in Pharmaceutical Chemistry and a B.Sc. in Chemistry from The Hebrew University of Jerusalem, Israel.

Sofi Glam
VP Business Development & Customer Success

Industry Experience
Sofi has more than 10 years’ experience in the pharmaceutical industry with over 8 years’ experience in the clinical supply management field. She serves as a clinical supplies subject matter expert and is a consultation focal point for various in-house interfaces and clients. As the Head of the Project Management Department, Sofi is responsible for the full IMP team of project managers.
Project Descriptions
Sofi is responsible for designing, planning, executing, and managing supply chains for worldwide clinical studies in all clinical phases in accordance with international guidelines and regulations, including GMP, GDP, and GCP guidelines. Sofi supervises the management of inventory, resupplies, and high-end cold-chain shipments for a number of top pharma companies. She is an expert in building effective customized project plans per customer needs while aligning both internal and external interfaces to ensure a timely delivery within the customer provided specifications, quality standards, and local and industry regulations. Plans include packaging, kit design, and labeling performed for both global and domestic studies. Sofi has Global supply management responsibilities and has vast experience in un-blinded supply management for both local and global studies as well as extensive experience managing work performed by contract manufacturing organizations (CMOs) and in integrating the needs of the CMO with the client needs to deliver clinical supplies in accordance with predefined deadlines.

Anna Schwartz Mor
Director of Regulatory and QA Operations and Responsible Pharmacist

Anna has been in Pharmaceutical Services and Management for over 15 years. She has extensive knowledge and experience in Pharmaceutical regulation, Pharmaceutical Production, Patient-Centric drug preparations and Clinical Trials Management. As the former Deputy Director of Pharmaceutical Services at Tel Aviv Sourasky Medical Center (Ichilov), she led a team of professional Pharmacists and developed procedures to enhance Quality and Safety.

Anna holds a Master in Pharma and a Master of Business Administration (MBA). She is a Certified Quality Auditor (CQA) and a Certified Manager of Quality/Organization Excellence (CMQ/OE).

Bat-El Darmon
Director of Quality and Compliance

Bat-El has over 13 years of experience in the pharmaceutical industry of commercial Medicinal Products of Israeli’s companies and Global company with logistic centers. Bat-El filled different quality positions and has experience with quality and compliance according to cGMP, GDP, IMC-GMP, IMC-GDP, ISO and local regulations.

As part of the quality positions, she gained experience in defining and implementing processes and systems following the relevant regulations.

Bat-El’s position provides quality Supervisory oversight of all QMS areas to ensure that Clinical Supply and Medical Cannabis are processed and managed in accordance with current regulations as well as customer requirements, and to provide overseeing compliance within the organization with laws, regulatory requirements, policies, and procedures.

Bat-El holds a B.A in Health Systems Management from Ariel University and attended several professional courses including internal and external auditing, GCP courses, Risk-Assessment management, Quality Assurance of Computerized System, and Information Security auditing.

Lilach Levinson
Warehouse Manager

Lilach has 30 years of logistics experience including many years in the pharmaceutical industry working under a strict GDP environment. Lilach has successfully passed numerous audits in the storage and distribution area. She has served as Dispatch/Warehouse manager at World Courier. Lilach has High analytical abilities, planning and finding solutions in real time as well as managing priorities within time constraints.
Lilach is responsible for the on-going Clinical Supply Management (CSM) of the Warehouse according to GMP, GDP principles and IMP SOPs. She also manages the Medical Cannabis inventory according to Israeli Medical Cannabis (IMC) unit requirements.

Aviva Feifer
Buisness Development Manager

Aviva has over 10 years experience in the biotech and pharma industries, with 3 years in the clinical supply management field. Before joining IMP, Aviva worked with companies to better understand, define, and emphasize their unmet medical need, work plans, and R&D milestones to develop grant portfolios to attain non-dilutive funding for project advancement. At IMP Aviva performs a crucial role in the growth and success of IMP by identifying new business opportunities while building and maintaining relationships with clients and partners. She is the first contact with new clients and enhances the set up phase by identifying client’s specific needs for their clinical trials, collaborates with vendors, and ensures the necessary regulatory documentation are reviewed and approved. Aviva holds a B.Sc. in Neuroscience from Bar Ilan University and an M.Sc. in Biomedical Sciences and Biochemistry from the Hebrew University.

Related Articles

The Use of Direct-to-Patient Methods in Decentralised Clinical Trials in Israel
Blog
The Use of Direct-to-Patient Methods in Decentralised Clinical Trials in Israel

Abstract: Direct-to-patient (DtP) methods in clinical trials have gained significant attention worldwide as they aim to improve patient access, engagement, and participation in research studies. This paper explores the status of DtP strategies in the context of clinical trials in Israel. It discusses the current landscape, challenges, benefits, and regulatory aspects of DtP initiatives in […]

Read more
Clinical trials in Israel during the Iron Swords War
Blog
Clinical trials in Israel during the Iron Swords War

Amid the current situation in Israel, IMP Services remains steadfast in our commitment to support and provide innovative solutions for your clinical trial logistics. Our goal is to ensure seamless operations for your trials, tailored to meet your unique needs. We’re pleased to share the recent update from the Israeli Ministry of Health. This letter […]

Read more
Healthcare Resilience & Clinical Trials in Israel
Blog
Healthcare Resilience & Clinical Trials in Israel

We would like to share with our clients and colleagues this important letter regarding the priority given to clinical trials in Israel by the MoH. We are always here to assist you in your clinical trial. Feel free to reach out!

Read more

FAQ

What is the role of IMP Clinical Supply Services in clinical trials?

IMP Clinical Supply Services plays a crucial role in clinical trials by providing comprehensive clinical supply management services. We ensure the importation, packaging, labeling, storage, and distribution of investigational products and medical equipment, all while adhering to strict compliance standards and local regulations.

How do you ensure the quality and safety of clinical trial supplies?

We maintain the quality and safety of clinical trial supplies by adhering to Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and Good Clinical Practice (GCP) standards as well as local regulations. Our commitment to compliance and quality management is unwavering, ensuring that supplies meet the highest standards.

What types of clinical trials do you support?

At IMP Clinical Supply Services, we support a diverse range of clinical trials across various therapeutic areas. Our tailored services cater to the unique needs of each trial, whether it's a small startup venture or a large pharmaceutical endeavor. From varying investigational product types to all medical device types and all phases, IMP handles the logistics and supply management, including importation of ancillaries and lab kits, ensuring seamless operations and compliance with regulatory standards. IMP provides all your logistic needs for Phase 1, Phase 2, Phase 3, Phase 4, After Care, Compassionate Use, 29C Importation, Blinded, Direct-to-Patient trials.

How do you handle the importation of investigational products and medical equipment?

IMP holds manufacturer's / importer's authorization from the Israeli MoH. This allows us to import all product types into Israel. Drug products must stop at our depot for release before being sent to the clinical site. Devices and lab kits / ancillaries can be sent directly to the clinical site or to our depot for storage and later distribution to the sites. Our dedicated importation personnel are experts in addressing the appropriate authorities, obtaining necessary licenses or dismissals, and ensuring that importation complies with regulations. We eliminate setbacks in importing and distributing supplies to investigational sites.

Can you design and pack study kits to follow our clinical trial protocol?

Absolutely. We specialize in custom packaging and labeling, ensuring that supplies meet the specific requirements of each clinical trial along with local regulations. Our team can design, edit, translate, and create labels in line with protocol specifications and local packaging regulations. We can assist you in designing your kit to optimize trial efficiency and maximize supply utilization.

What is most important in stability studies?

Stability is vital in defining the shelf life of investigational products during clinical trial performance. Our services include writing stability protocols and reports, storage in long term, intermediate, and accelerated conditions, and sampling according to your set protocol time points. We thus help you to guarantee the longevity and quality of your products throughout the trial.

What sets IMP Clinical Supply Services apart from competitors?

Our dedication to excellence, compliance, and a patient-centered approach sets us apart. We are known for our commitment to quality and innovation, with a team of professionals boasting over a decade of experience in the field.

Contact Us

    Back to top